Sun Pharmaceutical Industries Ltd Sues Novartis In US Court-Business Standard

Tuesday, 11 Jun 2013 03:15pm EDT 

Business Standard reported that Sun Pharmaceutical Industries Ltd has sued Novartis Pharmaceuticals Corp in the District Court of New Jersey, demanding rights to launch a generic version of the cancer drug before the Novartis patent expires. According to an industry source, the law suit filed by Sun Pharma Global FZE - Sun Pharma's US subsidiary -seeks a declaratory judgement against Novartis, allowing the Mumbai-based drug maker to sell generic imatinib mesylate in the US before one of the patents of the drug expires in the market. Imatinib mesylate is an active ingredient of Gleevec. 

Company Quote

37.6 +4.64%
6:29am EDT